Par Pharma Hit With Patent Suit Over Rythmol ANDA
Drug maker Reliant Pharmaceuticals Inc. has filed a federal patent infringement lawsuit against rival Par Pharmaceuticals Inc., accusing the company of violating its acquired patent related to the heart drug Rythmol...To view the full article, register now.
Already a subscriber? Click here to view full article